Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Plexin repeat family protein | 0.062 | 0.4572 | 0.8205 |
Schistosoma mansoni | hypothetical protein | 0.0265 | 0.161 | 0.3522 |
Brugia malayi | IPT/TIG domain containing protein | 0.0116 | 0.0369 | 0.041 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0089 | 0.0148 | 0.5 |
Echinococcus granulosus | transcription factor collier | 0.0116 | 0.0369 | 0.0384 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0089 | 0.0148 | 0.5 |
Onchocerca volvulus | 0.0265 | 0.161 | 0.3305 | |
Brugia malayi | Sema domain containing protein | 0.0265 | 0.161 | 0.2712 |
Onchocerca volvulus | 0.062 | 0.4572 | 1 | |
Echinococcus granulosus | roundabout 2 | 0.0075 | 0.0028 | 0.0029 |
Schistosoma mansoni | hypothetical protein | 0.0355 | 0.2363 | 0.5169 |
Brugia malayi | Probable exocyst complex component Sec5 | 0.0116 | 0.0369 | 0.041 |
Schistosoma mansoni | hypothetical protein | 0.0116 | 0.0369 | 0.0808 |
Echinococcus multilocularis | roundabout 2 | 0.0075 | 0.0028 | 0.005 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0089 | 0.0148 | 0.0154 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.161 | 0.2871 |
Schistosoma mansoni | amine oxidase | 0.0089 | 0.0148 | 0.0323 |
Echinococcus granulosus | semaphorin 1A | 0.0265 | 0.161 | 0.1675 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0148 | 0.0218 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0089 | 0.0148 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0089 | 0.0148 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0369 | 0.0619 |
Brugia malayi | hypothetical protein | 0.0265 | 0.161 | 0.2712 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0148 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0148 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0148 | 0.0218 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0265 | 0.161 | 0.2871 |
Plasmodium vivax | hypothetical protein, conserved | 0.0089 | 0.0148 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.161 | 0.2871 |
Schistosoma mansoni | semaphorin 5-related | 0.0265 | 0.161 | 0.3522 |
Echinococcus multilocularis | exocyst complex component 2 | 0.0116 | 0.0369 | 0.0666 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0116 | 0.0369 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0369 | 0.0619 |
Brugia malayi | DNA-binding protein LAG-1 | 0.0116 | 0.0369 | 0.041 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0265 | 0.161 | 0.2871 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0256 | 0.1534 | 0.2733 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.127 | 1 | 1 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0089 | 0.0148 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0089 | 0.0148 | 0.0323 |
Schistosoma mansoni | fibrocystin l | 0.0116 | 0.0369 | 0.0808 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0089 | 0.0148 | 0.0323 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0265 | 0.161 | 0.3522 |
Brugia malayi | Sema domain containing protein | 0.0265 | 0.161 | 0.2712 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0369 | 0.0619 |
Echinococcus multilocularis | plexin a4 | 0.0736 | 0.5539 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0089 | 0.0148 | 0.0267 |
Schistosoma mansoni | plexin | 0.0355 | 0.2363 | 0.5169 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0089 | 0.0148 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0089 | 0.0148 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0369 | 0.0619 |
Echinococcus multilocularis | transcription factor collier | 0.0116 | 0.0369 | 0.0666 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.1181 | 0.9254 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.161 | 0.2871 |
Plasmodium vivax | hypothetical protein, conserved | 0.0089 | 0.0148 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0116 | 0.0369 | 0.5 |
Brugia malayi | plexin A | 0.0736 | 0.5539 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.062 | 0.4572 | 0.8244 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0089 | 0.0148 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0116 | 0.0369 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0155 | 0.0699 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0089 | 0.0148 | 0.0267 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0089 | 0.0148 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0089 | 0.0148 | 0.0154 |
Echinococcus granulosus | exocyst complex component 2 | 0.0116 | 0.0369 | 0.0384 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0089 | 0.0148 | 0.5 |
Echinococcus granulosus | macrophage colony stimulating factor 1 receptor | 0.1224 | 0.9614 | 1 |
Echinococcus multilocularis | 0.0089 | 0.0148 | 0.0267 | |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.161 | 0.2871 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0116 | 0.0369 | 0.5 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0203 | 0.1093 | 0.2137 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.161 | 0.2871 |
Echinococcus multilocularis | hypothetical protein | 0.0265 | 0.161 | 0.2907 |
Echinococcus granulosus | plexin a4 | 0.0736 | 0.5539 | 0.5762 |
Echinococcus granulosus | semaphorin 5B | 0.0265 | 0.161 | 0.1675 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Loa Loa (eye worm) | plexin A | 0.0736 | 0.5539 | 1 |
Brugia malayi | hypothetical protein | 0.0265 | 0.161 | 0.2712 |
Leishmania major | UDP-galactopyranose mutase | 0.0089 | 0.0148 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0355 | 0.2363 | 0.4237 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.161 | 0.2871 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0089 | 0.0148 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0148 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0148 | 0.0218 |
Schistosoma mansoni | plexin | 0.062 | 0.4572 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0089 | 0.0148 | 0.0323 |
Schistosoma mansoni | hypothetical protein | 0.0116 | 0.0369 | 0.0808 |
Onchocerca volvulus | 0.0152 | 0.0671 | 0.1182 | |
Echinococcus multilocularis | semaphorin 5B | 0.0265 | 0.161 | 0.2907 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.0369 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0256 | 0.1534 | 0.2571 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0155 | 0.0699 | 1 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0116 | 0.0369 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 1.7 mg kg-1 | Compound was tested for antidepressant activity by determining the reversal of tetrabenazine-induced ptosis upon oral administration; 0.9-3.3 | ChEMBL. | 7265119 |
ED50 (functional) | = 1.7 mg kg-1 | Compound was tested for antidepressant activity by determining the reversal of tetrabenazine-induced ptosis upon oral administration; 0.9-3.3 | ChEMBL. | 7265119 |
ED50 (functional) | = 12 mg kg-1 | Effect on pupil dilation was measured in mice upon oral administration | ChEMBL. | 7265119 |
ED50 (functional) | = 12 mg kg-1 | The effect of the compound on ataxia in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | = 12 mg kg-1 | Effect on pupil dilation was measured in mice upon oral administration | ChEMBL. | 7265119 |
ED50 (functional) | = 12 mg kg-1 | The effect of the compound on ataxia in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | > 81 mg kg-1 | Antidepressant activity by determining the decreased exploratory activity in mice upon oral administration | ChEMBL. | 7265119 |
ED50 (functional) | > 81 mg kg-1 | Antidepressant activity by determining the decreased exploratory activity in mice upon oral administration | ChEMBL. | 7265119 |
ED50 (functional) | = 200 mg kg-1 | The effect of the compound on 24-hour mortality in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | = 200 mg kg-1 | The effect of the compound on 24-hour mortality in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | > 324 mg kg-1 | The effect of the compound on excitement was measured in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | > 324 mg kg-1 | The effect of the compound on electroshock protection in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | > 324 mg kg-1 | The effect of the compound on excitement was measured in mice following oral administration | ChEMBL. | 7265119 |
ED50 (functional) | > 324 mg kg-1 | The effect of the compound on electroshock protection in mice following oral administration | ChEMBL. | 7265119 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.